BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, today announced that the company has changed its name from Allergen Research Corporation (ARC) to Aimmune Therapeutics.
As Aimmune Therapeutics, the company has introduced a new corporate identity and logo that honors its heritage while reflecting its evolution and steadfast mission: to address the urgent and growing unmet need to protect people with food allergies from the dangers of accidental exposure to their allergens. For more information, please see Aimmune’s new website at www.aimmune.com.
Help employers find you! Check out all the jobs and post your resume.
